111 related articles for article (PubMed ID: 4135044)
1. [Intrahepatic cholestasis following ovosiston].
Kraatz G; Linke A
Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1194-6. PubMed ID: 4135044
[No Abstract] [Full Text] [Related]
2. [Therapy of dysmenorrhea].
Cazzola D
Ann Ostet Ginecol Med Perinat; 1975; 96(3):189-201. PubMed ID: 59568
[No Abstract] [Full Text] [Related]
3. [Jaundice in intrahepatic cholestasis after ovulation inhibitors].
Piesbergen H
Med Welt; 1968 Feb; 9():451-3. PubMed ID: 4181421
[No Abstract] [Full Text] [Related]
4. [Intrahepatic cholestasis in hormonal contraception--a case with a difficult and expensive differential diagnosis].
Böhme HH; Otto HJ
Zentralbl Gynakol; 1985; 107(5):311-2. PubMed ID: 2581395
[TBL] [Abstract][Full Text] [Related]
5. [Biphasic therapy using Sequenz-Ovosiston for hormonal contraception].
Ebeling K; Kühndel K; Rothe K; Canzler E
Z Arztl Fortbild (Jena); 1971 Dec; 65(24):1275-8. PubMed ID: 4111418
[No Abstract] [Full Text] [Related]
6. [Drug-induced liver damage following use of the oral contraceptive Femigen].
Kwaśniewska W; Raczyńska A
Patol Pol; 1974; 25(1):101-6. PubMed ID: 4133325
[No Abstract] [Full Text] [Related]
7. [Menstruation disorders due to Ovosiston medication].
Kühndel K; Ebeling K; Rothe K
Dtsch Gesundheitsw; 1971 Jan; 26(3):109-13. PubMed ID: 4106361
[No Abstract] [Full Text] [Related]
8. Primary dysmenorrhea: combination vs sequential therapy.
Buttram VC; Kaufman RH
Tex Med; 1969 Aug; 65(8):52-5. PubMed ID: 4185963
[No Abstract] [Full Text] [Related]
9. [Therapy of cholestasis in infectious hepatitis].
Semmler H; Mittmann W; Rosenberg E
Dtsch Gesundheitsw; 1970 Jul; 25(29):1341-4. PubMed ID: 5509652
[No Abstract] [Full Text] [Related]
10. [Cholestatic icterus after intake of ovulation inhibitors].
Pansold E; Fischer I; Pfeifer K
Dtsch Gesundheitsw; 1974 Mar; 29(10):470-5. PubMed ID: 4142434
[TBL] [Abstract][Full Text] [Related]
11. [Sequenz-Ovosiston as a contraceptive agent].
Zwahr C
Zentralbl Gynakol; 1972 Dec; 94(49):1722-5. PubMed ID: 4119508
[No Abstract] [Full Text] [Related]
12. [Coronary infarction associated with ovulation inhibitors].
Dejaco RM; Hartl O; Pürgyi P
Wien Med Wochenschr; 1972 Nov; 122(43):630-2. PubMed ID: 4120546
[No Abstract] [Full Text] [Related]
13. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology].
Müller R; Kempf HJ; Eckert L
Zentralbl Gynakol; 1968 Nov; 90(46):1545-55. PubMed ID: 4179333
[No Abstract] [Full Text] [Related]
14. [Clinical results of Lunarol, synthetic corpus luteum and follicle hormones preparation with special reference to corpus luteum insufficiency and amenorrhea].
Iizuka R; Koi H; Saga M; Shibuya T; Hongo K
Sanfujinka No Jissai; 1970; 19(3):322-30. PubMed ID: 4192774
[No Abstract] [Full Text] [Related]
15. [Contraceptives, application and side effects from the dermatological viewpoint].
Schäfer I
Dtsch Gesundheitsw; 1971 Feb; 26(9):405-9. PubMed ID: 4104204
[No Abstract] [Full Text] [Related]
16. [Changes in heparinocytes during the administration of Depositon and Sequenz-Ovosiston].
Frick G; Göretzlehner G
Zentralbl Gynakol; 1975; 97(8):488-93. PubMed ID: 56830
[TBL] [Abstract][Full Text] [Related]
17. ["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne].
Zwahr C
Dtsch Gesundheitsw; 1970 Nov; 25(47):2247-50. PubMed ID: 4099776
[No Abstract] [Full Text] [Related]
18. [Serum enzyme examinations in the climacteric under the treatment with the estrogen-gestagen combination Ovosiston].
Müller W; Bonow A; Klinger G; Hempel E
Zentralbl Gynakol; 1969 Jul; 91(27):867-73. PubMed ID: 4188685
[No Abstract] [Full Text] [Related]
19. [Liver function and glucose tolerance during treatment with the oral contraceptive ovosiston].
Heller H
Dtsch Gesundheitsw; 1972 Jun; 27(22):1035-8. PubMed ID: 4114489
[No Abstract] [Full Text] [Related]
20. Significance of dysmenorrhea in infertility. Report of a preliminary study of therapy with a sequential estrogen-progestagen regimen.
Roland M; Clyman M; Decker A; Ober WB
Pac Med Surg; 1966; 74(3):135-8. PubMed ID: 4160710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
